APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GLP-1 Injection Industry Growth and Trends Forecast to 2032

26 December 2025113 pages

Choose your research edition.

Industry ResearchGLP-1 Injection Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Injection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal GLP-1 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Injection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global GLP-1 Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Injection include Zhengda Tianqing, Innovent Biologics, Wanbang Biopharma, Sihuan Pharmaceuticals, CSPC Pharmaceutical Group, Shanghai Benemae Biopharmaceuticals Co., Ltd., Pegbio, Eli Lilly and Huadong Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GLP-1 Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GLP-1 Injection market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GLP-1 Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GLP-1 Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GLP-1 Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GLP-1 Injection Market by Company

Zhengda Tianqing

Innovent Biologics

Wanbang Biopharma

Sihuan Pharmaceuticals

CSPC Pharmaceutical Group

Shanghai Benemae Biopharmaceuticals Co., Ltd.

Pegbio

Eli Lilly

Huadong Medicine

Hongyun Huaning

Hengrui Medicine

Hansoh Pharmaceuticals

Gan & Lee Pharmaceuticals

Borui Pharmaceuticals

Imeik

Novo Nordisk

GLP-1 Injection Segment by Type

Benaglutide

Liraglutide

Semaglutide

Tirzepatide

Others

GLP-1 Injection Segment by Application

Diabetes

Obesity

Others

GLP-1 Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GLP-1 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Benaglutide Table 2. Major Company of Liraglutide Table 3. Major Company of Semaglutide Table 4. Major Company of Tirzepatide Table 5. Major Company of Others Table 6. Global GLP-1 Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 8. Global GLP-1 Injection Sales Market Share in Volume by Type (2021-2026) Table 9. Global GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 10. Global GLP-1 Injection Sales Market Share in Value by Type (2021-2026) Table 11. Global GLP-1 Injection Price by Type (2021-2026) & (US$/Unit) Table 12. Global GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 13. Global GLP-1 Injection Sales Market Share in Volume by Type (2027-2032) Table 14. Global GLP-1 Injection Sales by Type (2027-2032) & (US$ Million) Table 15. Global GLP-1 Injection Sales Market Share in Value by Type (2027-2032) Table 16. Global GLP-1 Injection Price by Type (2027-2032) & (US$/Unit) Table 17. North America GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 18. North America GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Europe GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 20. Europe GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 22. Asia-Pacific GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 24. Latin America GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 26. Middle East and Africa GLP-1 Injection Sales by Type (2021-2026) & (US$ Million) Table 27. GLP-1 Injection Industry Trends Table 28. GLP-1 Injection Industry Drivers Table 29. GLP-1 Injection Industry Opportunities and Challenges Table 30. GLP-1 Injection Industry Restraints Table 31. Global GLP-1 Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global GLP-1 Injection Revenue Market Share by Company (2021-2026) Table 33. Global GLP-1 Injection Sales by Company (2021-2026) & (Units) Table 34. Global GLP-1 Injection Sales Share by Company (2021-2026) Table 35. Global GLP-1 Injection Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global GLP-1 Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global GLP-1 Injection Major Company Production Sites and Headquarters Table 38. Global GLP-1 Injection Company, Product Type & Application Table 39. Global GLP-1 Injection Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global GLP-1 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global GLP-1 Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global GLP-1 Injection Sales by Region (2021-2026) & (Units) Table 44. Global GLP-1 Injection Sales Market Share in Volume by Region (2021-2026) Table 45. Global GLP-1 Injection Sales by Region (2021-2026) & (US$ Million) Table 46. Global GLP-1 Injection Sales Market Share in Value by Region (2021-2026) Table 47. Global GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global GLP-1 Injection Sales by Region (2027-2032) & (Units) Table 49. Global GLP-1 Injection Sales Market Share in Volume by Region (2027-2032) Table 50. Global GLP-1 Injection Sales by Region (2027-2032) & (US$ Million) Table 51. Global GLP-1 Injection Sales Market Share in Value by Region (2027-2032) Table 52. Global GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global GLP-1 Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 55. Global GLP-1 Injection Sales Market Share in Volume by Application (2021-2026) Table 56. Global GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 57. Global GLP-1 Injection Sales Market Share in Value by Application (2021-2026) Table 58. Global GLP-1 Injection Price by Application (2021-2026) & (US$/Unit) Table 59. Global GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 60. Global GLP-1 Injection Sales Market Share in Volume by Application (2027-2032) Table 61. Global GLP-1 Injection Sales by Application (2027-2032) & (US$ Million) Table 62. Global GLP-1 Injection Sales Market Share in Value by Application (2027-2032) Table 63. Global GLP-1 Injection Price by Application (2027-2032) & (US$/Unit) Table 64. North America GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 65. North America GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Europe GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 67. Europe GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 69. Asia-Pacific GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 71. Latin America GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 73. Middle East and Africa GLP-1 Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Zhengda Tianqing Company Information Table 75. Zhengda Tianqing Business Overview Table 76. Zhengda Tianqing GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhengda Tianqing GLP-1 Injection Product Portfolio Table 78. Zhengda Tianqing Recent Development Table 79. Innovent Biologics Company Information Table 80. Innovent Biologics Business Overview Table 81. Innovent Biologics GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Innovent Biologics GLP-1 Injection Product Portfolio Table 83. Innovent Biologics Recent Development Table 84. Wanbang Biopharma Company Information Table 85. Wanbang Biopharma Business Overview Table 86. Wanbang Biopharma GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Wanbang Biopharma GLP-1 Injection Product Portfolio Table 88. Wanbang Biopharma Recent Development Table 89. Sihuan Pharmaceuticals Company Information Table 90. Sihuan Pharmaceuticals Business Overview Table 91. Sihuan Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio Table 93. Sihuan Pharmaceuticals Recent Development Table 94. CSPC Pharmaceutical Group Company Information Table 95. CSPC Pharmaceutical Group Business Overview Table 96. CSPC Pharmaceutical Group GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio Table 98. CSPC Pharmaceutical Group Recent Development Table 99. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 100. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 101. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio Table 103. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 104. Pegbio Company Information Table 105. Pegbio Business Overview Table 106. Pegbio GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pegbio GLP-1 Injection Product Portfolio Table 108. Pegbio Recent Development Table 109. Eli Lilly Company Information Table 110. Eli Lilly Business Overview Table 111. Eli Lilly GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Eli Lilly GLP-1 Injection Product Portfolio Table 113. Eli Lilly Recent Development Table 114. Huadong Medicine Company Information Table 115. Huadong Medicine Business Overview Table 116. Huadong Medicine GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Huadong Medicine GLP-1 Injection Product Portfolio Table 118. Huadong Medicine Recent Development Table 119. Hongyun Huaning Company Information Table 120. Hongyun Huaning Business Overview Table 121. Hongyun Huaning GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hongyun Huaning GLP-1 Injection Product Portfolio Table 123. Hongyun Huaning Recent Development Table 124. Hengrui Medicine Company Information Table 125. Hengrui Medicine Business Overview Table 126. Hengrui Medicine GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hengrui Medicine GLP-1 Injection Product Portfolio Table 128. Hengrui Medicine Recent Development Table 129. Hansoh Pharmaceuticals Company Information Table 130. Hansoh Pharmaceuticals Business Overview Table 131. Hansoh Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio Table 133. Hansoh Pharmaceuticals Recent Development Table 134. Gan & Lee Pharmaceuticals Company Information Table 135. Gan & Lee Pharmaceuticals Business Overview Table 136. Gan & Lee Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio Table 138. Gan & Lee Pharmaceuticals Recent Development Table 139. Borui Pharmaceuticals Company Information Table 140. Borui Pharmaceuticals Business Overview Table 141. Borui Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Borui Pharmaceuticals GLP-1 Injection Product Portfolio Table 143. Borui Pharmaceuticals Recent Development Table 144. Imeik Company Information Table 145. Imeik Business Overview Table 146. Imeik GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Imeik GLP-1 Injection Product Portfolio Table 148. Imeik Recent Development Table 149. Novo Nordisk Company Information Table 150. Novo Nordisk Business Overview Table 151. Novo Nordisk GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Novo Nordisk GLP-1 Injection Product Portfolio Table 153. Novo Nordisk Recent Development Table 154. North America GLP-1 Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 155. North America GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 156. North America GLP-1 Injection Sales Market Share by Country (2021-2026) Table 157. North America GLP-1 Injection Sales Forecast by Country (2027-2032) & (Units) Table 158. North America GLP-1 Injection Sales Market Share Forecast by Country (2027-2032) Table 159. North America GLP-1 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. North America GLP-1 Injection Market Size by Country (2021-2026) & (US$ Million) Table 161. North America GLP-1 Injection Market Share by Country (2021-2026) Table 162. North America GLP-1 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. North America GLP-1 Injection Market Share Forecast by Country (2027-2032) Table 164. Europe GLP-1 Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 165. Europe GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 166. Europe GLP-1 Injection Sales Market Share by Country (2021-2026) Table 167. Europe GLP-1 Injection Sales Forecast by Country (2027-2032) & (Units) Table 168. Europe GLP-1 Injection Sales Market Share Forecast by Country (2027-2032) Table 169. Europe GLP-1 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Europe GLP-1 Injection Market Size by Country (2021-2026) & (US$ Million) Table 171. Europe GLP-1 Injection Market Share by Country (2021-2026) Table 172. Europe GLP-1 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Europe GLP-1 Injection Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific GLP-1 Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 176. Asia-Pacific GLP-1 Injection Sales Market Share by Country (2021-2026) Table 177. Asia-Pacific GLP-1 Injection Sales Forecast by Country (2027-2032) & (Units) Table 178. Asia-Pacific GLP-1 Injection Sales Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific GLP-1 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific GLP-1 Injection Market Size by Country (2021-2026) & (US$ Million) Table 181. Asia-Pacific GLP-1 Injection Market Share by Country (2021-2026) Table 182. Asia-Pacific GLP-1 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Asia-Pacific GLP-1 Injection Market Share Forecast by Country (2027-2032) Table 184. Latin America GLP-1 Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 185. Latin America GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 186. Latin America GLP-1 Injection Sales Market Share by Country (2021-2026) Table 187. Latin America GLP-1 Injection Sales Forecast by Country (2027-2032) & (Units) Table 188. Latin America GLP-1 Injection Sales Market Share Forecast by Country (2027-2032) Table 189. Latin America GLP-1 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Latin America GLP-1 Injection Market Size by Country (2021-2026) & (US$ Million) Table 191. Latin America GLP-1 Injection Market Share by Country (2021-2026) Table 192. Latin America GLP-1 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Latin America GLP-1 Injection Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa GLP-1 Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 196. Middle East and Africa GLP-1 Injection Sales Market Share by Country (2021-2026) Table 197. Middle East and Africa GLP-1 Injection Sales Forecast by Country (2027-2032) & (Units) Table 198. Middle East and Africa GLP-1 Injection Sales Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa GLP-1 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa GLP-1 Injection Market Size by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa GLP-1 Injection Market Share by Country (2021-2026) Table 202. Middle East and Africa GLP-1 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Middle East and Africa GLP-1 Injection Market Share Forecast by Country (2027-2032) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. GLP-1 Injection Distributors List Table 207. GLP-1 Injection Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. GLP-1 Injection Image Figure 2. Global GLP-1 Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Injection Sales (2021-2032) & (Units) Figure 5. Benaglutide Image Figure 6. Global Benaglutide Sales YoY Growth (2021-2032) & (Units) Figure 7. Liraglutide Image Figure 8. Global Liraglutide Sales YoY Growth (2021-2032) & (Units) Figure 9. Semaglutide Image Figure 10. Global Semaglutide Sales YoY Growth (2021-2032) & (Units) Figure 11. Tirzepatide Image Figure 12. Global Tirzepatide Sales YoY Growth (2021-2032) & (Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 15. Global GLP-1 Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global GLP-1 Injection Market Share by Type 2025 VS 2032 Figure 17. North America GLP-1 Injection Sales Market Share in Volume by Type in 2025 Figure 18. North America GLP-1 Injection Sales Market Share in Value by Type in 2025 Figure 19. Europe GLP-1 Injection Sales Market Share in Volume by Type in 2025 Figure 20. Europe GLP-1 Injection Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific GLP-1 Injection Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific GLP-1 Injection Sales Market Share in Value by Type in 2025 Figure 23. Latin America GLP-1 Injection Sales Market Share in Volume by Type in 2025 Figure 24. Latin America GLP-1 Injection Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa GLP-1 Injection Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa GLP-1 Injection Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 GLP-1 Injection Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Diabetes Image Figure 30. Global Diabetes Sales YoY Growth (2021-2032) & (Units) Figure 31. Obesity Image Figure 32. Global Obesity Sales YoY Growth (2021-2032) & (Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 35. Global GLP-1 Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global GLP-1 Injection Market Share by Application 2025 VS 2032 Figure 37. North America GLP-1 Injection Sales Market Share in Volume by Application in 2025 Figure 38. North America GLP-1 Injection Sales Market Share in Value by Application in 2025 Figure 39. Europe GLP-1 Injection Sales Market Share in Volume by Application in 2025 Figure 40. Europe GLP-1 Injection Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific GLP-1 Injection Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific GLP-1 Injection Sales Market Share in Value by Application in 2025 Figure 43. Latin America GLP-1 Injection Sales Market Share in Volume by Application in 2025 Figure 44. Latin America GLP-1 Injection Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa GLP-1 Injection Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa GLP-1 Injection Sales Market Share in Value by Application in 2025 Figure 47. North America GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. North America GLP-1 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America GLP-1 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America GLP-1 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Europe GLP-1 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe GLP-1 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe GLP-1 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Asia-Pacific GLP-1 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific GLP-1 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific GLP-1 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Latin America GLP-1 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America GLP-1 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America GLP-1 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Middle East and Africa GLP-1 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa GLP-1 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa GLP-1 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. GLP-1 Injection Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. GLP-1 Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Benaglutide
  • Liraglutide
  • Semaglutide
  • Tirzepatide
  • Others
Applications
  • Diabetes
  • Obesity
  • Others
Companies covered
  • Zhengda Tianqing
  • Innovent Biologics
  • Wanbang Biopharma
  • Sihuan Pharmaceuticals
  • CSPC Pharmaceutical Group
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • Pegbio
  • Eli Lilly
  • Huadong Medicine
  • Hongyun Huaning
  • Hengrui Medicine
  • Hansoh Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Borui Pharmaceuticals
  • Imeik
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GLP-1 Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GLP-1 Injection Market by Type
  6. 1.3.1 Benaglutide
  7. 1.3.2 Liraglutide
  8. 1.3.3 Semaglutide
  9. 1.3.4 Tirzepatide
  10. 1.3.5 Others
  11. 1.4 Global GLP-1 Injection Market Size by Type
  12. 1.4.1 Global GLP-1 Injection Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global GLP-1 Injection Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global GLP-1 Injection Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America GLP-1 Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe GLP-1 Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific GLP-1 Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America GLP-1 Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa GLP-1 Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GLP-1 Injection Industry Trends
  2. 2.2 GLP-1 Injection Industry Drivers
  3. 2.3 GLP-1 Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GLP-1 Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by GLP-1 Injection Sales (2021-2026)
  3. 3.3 Global Top Players by GLP-1 Injection Price (2021-2026)
  4. 3.4 Global GLP-1 Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Injection Major Company Production Sites & Headquarters
  6. 3.6 Global GLP-1 Injection Company, Product Type & Application
  7. 3.7 Global GLP-1 Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GLP-1 Injection Tier 1, Tier 2, and Tier 3
4 GLP-1 Injection Regional Status and Outlook
  1. 4.1 Global GLP-1 Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GLP-1 Injection Historic Market Size by Region
  3. 4.2.1 Global GLP-1 Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GLP-1 Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GLP-1 Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GLP-1 Injection Forecasted Market Size by Region
  7. 4.3.1 Global GLP-1 Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GLP-1 Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GLP-1 Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GLP-1 Injection by Application
  1. 5.1 GLP-1 Injection Market by Application
  2. 5.1.1 Diabetes
  3. 5.1.2 Obesity
  4. 5.1.3 Others
  5. 5.2 Global GLP-1 Injection Market Size by Application
  6. 5.2.1 Global GLP-1 Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global GLP-1 Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global GLP-1 Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America GLP-1 Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe GLP-1 Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific GLP-1 Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America GLP-1 Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa GLP-1 Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhengda Tianqing
  2. 6.1.1 Zhengda Tianqing Company Information
  3. 6.1.2 Zhengda Tianqing Business Overview
  4. 6.1.3 Zhengda Tianqing GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhengda Tianqing GLP-1 Injection Product Portfolio
  6. 6.1.5 Zhengda Tianqing Recent Developments
  7. 6.2 Innovent Biologics
  8. 6.2.1 Innovent Biologics Company Information
  9. 6.2.2 Innovent Biologics Business Overview
  10. 6.2.3 Innovent Biologics GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Innovent Biologics GLP-1 Injection Product Portfolio
  12. 6.2.5 Innovent Biologics Recent Developments
  13. 6.3 Wanbang Biopharma
  14. 6.3.1 Wanbang Biopharma Company Information
  15. 6.3.2 Wanbang Biopharma Business Overview
  16. 6.3.3 Wanbang Biopharma GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wanbang Biopharma GLP-1 Injection Product Portfolio
  18. 6.3.5 Wanbang Biopharma Recent Developments
  19. 6.4 Sihuan Pharmaceuticals
  20. 6.4.1 Sihuan Pharmaceuticals Company Information
  21. 6.4.2 Sihuan Pharmaceuticals Business Overview
  22. 6.4.3 Sihuan Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio
  24. 6.4.5 Sihuan Pharmaceuticals Recent Developments
  25. 6.5 CSPC Pharmaceutical Group
  26. 6.5.1 CSPC Pharmaceutical Group Company Information
  27. 6.5.2 CSPC Pharmaceutical Group Business Overview
  28. 6.5.3 CSPC Pharmaceutical Group GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio
  30. 6.5.5 CSPC Pharmaceutical Group Recent Developments
  31. 6.6 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  32. 6.6.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  33. 6.6.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  34. 6.6.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio
  36. 6.6.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  37. 6.7 Pegbio
  38. 6.7.1 Pegbio Company Information
  39. 6.7.2 Pegbio Business Overview
  40. 6.7.3 Pegbio GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pegbio GLP-1 Injection Product Portfolio
  42. 6.7.5 Pegbio Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly GLP-1 Injection Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Huadong Medicine
  50. 6.9.1 Huadong Medicine Company Information
  51. 6.9.2 Huadong Medicine Business Overview
  52. 6.9.3 Huadong Medicine GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Huadong Medicine GLP-1 Injection Product Portfolio
  54. 6.9.5 Huadong Medicine Recent Developments
  55. 6.10 Hongyun Huaning
  56. 6.10.1 Hongyun Huaning Company Information
  57. 6.10.2 Hongyun Huaning Business Overview
  58. 6.10.3 Hongyun Huaning GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hongyun Huaning GLP-1 Injection Product Portfolio
  60. 6.10.5 Hongyun Huaning Recent Developments
  61. 6.11 Hengrui Medicine
  62. 6.11.1 Hengrui Medicine Company Information
  63. 6.11.2 Hengrui Medicine Business Overview
  64. 6.11.3 Hengrui Medicine GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hengrui Medicine GLP-1 Injection Product Portfolio
  66. 6.11.5 Hengrui Medicine Recent Developments
  67. 6.12 Hansoh Pharmaceuticals
  68. 6.12.1 Hansoh Pharmaceuticals Company Information
  69. 6.12.2 Hansoh Pharmaceuticals Business Overview
  70. 6.12.3 Hansoh Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio
  72. 6.12.5 Hansoh Pharmaceuticals Recent Developments
  73. 6.13 Gan & Lee Pharmaceuticals
  74. 6.13.1 Gan & Lee Pharmaceuticals Company Information
  75. 6.13.2 Gan & Lee Pharmaceuticals Business Overview
  76. 6.13.3 Gan & Lee Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio
  78. 6.13.5 Gan & Lee Pharmaceuticals Recent Developments
  79. 6.14 Borui Pharmaceuticals
  80. 6.14.1 Borui Pharmaceuticals Company Information
  81. 6.14.2 Borui Pharmaceuticals Business Overview
  82. 6.14.3 Borui Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Borui Pharmaceuticals GLP-1 Injection Product Portfolio
  84. 6.14.5 Borui Pharmaceuticals Recent Developments
  85. 6.15 Imeik
  86. 6.15.1 Imeik Company Information
  87. 6.15.2 Imeik Business Overview
  88. 6.15.3 Imeik GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Imeik GLP-1 Injection Product Portfolio
  90. 6.15.5 Imeik Recent Developments
  91. 6.16 Novo Nordisk
  92. 6.16.1 Novo Nordisk Company Information
  93. 6.16.2 Novo Nordisk Business Overview
  94. 6.16.3 Novo Nordisk GLP-1 Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Novo Nordisk GLP-1 Injection Product Portfolio
  96. 6.16.5 Novo Nordisk Recent Developments
7 North America by Country
  1. 7.1 North America GLP-1 Injection Sales by Country
  2. 7.1.1 North America GLP-1 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GLP-1 Injection Sales by Country (2021-2026)
  4. 7.1.3 North America GLP-1 Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America GLP-1 Injection Market Size by Country
  6. 7.2.1 North America GLP-1 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GLP-1 Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America GLP-1 Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GLP-1 Injection Sales by Country
  2. 8.1.1 Europe GLP-1 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GLP-1 Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe GLP-1 Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GLP-1 Injection Market Size by Country
  6. 8.2.1 Europe GLP-1 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GLP-1 Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe GLP-1 Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GLP-1 Injection Sales by Country
  2. 9.1.1 Asia-Pacific GLP-1 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GLP-1 Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GLP-1 Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GLP-1 Injection Market Size by Country
  6. 9.2.1 Asia-Pacific GLP-1 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GLP-1 Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GLP-1 Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GLP-1 Injection Sales by Country
  2. 10.1.1 South America GLP-1 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GLP-1 Injection Sales by Country (2021-2026)
  4. 10.1.3 South America GLP-1 Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America GLP-1 Injection Market Size by Country
  6. 10.2.1 South America GLP-1 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GLP-1 Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America GLP-1 Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GLP-1 Injection Sales by Country
  2. 11.1.1 Middle East and Africa GLP-1 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GLP-1 Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GLP-1 Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GLP-1 Injection Market Size by Country
  6. 11.2.1 Middle East and Africa GLP-1 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GLP-1 Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GLP-1 Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GLP-1 Injection Value Chain Analysis
  2. 12.1.1 GLP-1 Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GLP-1 Injection Production Mode & Process
  7. 12.2 GLP-1 Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GLP-1 Injection Distributors
  10. 12.2.3 GLP-1 Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst